Association of platelet function with depression and its treatment with sertraline in patients with chronic kidney disease: analysis of a randomized trial

Association of platelet function with depression and its treatment with sertraline in patients with chronic kidney disease: analysis of a randomized trial

Abstract Background Major Depressive Disorder (MDD) can lead to adverse cardiovascular outcomes in patients with chronic kidney disease (CKD). Although one of the proposed mechanisms is heightened platelet activation, effects of MDD and its treatment with a selective serotonin reuptake inhibitor (SS...

Full description

Bibliographic Details
Main Authors: Nishank Jain, Fei Wan, Monica Kothari, Anuoluwapo Adelodun, Jerry Ware, Ravi Sarode, S. Susan Hedayati
Format: Article
Language:English
Published: BMC 2019-10-01
Series:BMC Nephrology
Subjects:
Depression
Chronic kidney disease
Platelet function
Platelet aggregation
Sertraline
Selective serotonin reuptake inhibitors
Online Access:http://link.springer.com/article/10.1186/s12882-019-1576-7

Internet

http://link.springer.com/article/10.1186/s12882-019-1576-7

Similar Items